Martijn H van der Ree
Overview
Explore the profile of Martijn H van der Ree including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miszczyk M, Hoeksema W, Kuna K, Blamek S, Cuculich P, Grehn M, et al.
Heart Rhythm
. 2024 Jul;
22(1):80-89.
PMID: 39032525
Stereotactic arrhythmia radioablation (STAR) is a noninvasive treatment of refractory ventricular tachycardia (VT). In this study, we aimed to systematically review prospective trials on STAR and pool harmonized outcome measures...
2.
Verheul L, van der Ree M, Groeneveld S, Mulder B, Christiaans I, Kapel G, et al.
Europace
. 2023 Nov;
25(11).
PMID: 37967257
Aims: During the diagnostic work-up of patients with idiopathic ventricular fibrillation (VF), next-generation sequencing panels can be considered to identify genotypes associated with arrhythmias. However, consensus for gene panel testing...
3.
van der Ree M, Cuculich P, Van Herk M, Hugo G, Balt J, Bates M, et al.
Front Cardiovasc Med
. 2023 Oct;
10:1267800.
PMID: 37799779
Background: Stereotactic arrhythmia radioablation (STAR) is a potential new therapy for patients with refractory ventricular tachycardia (VT). The arrhythmogenic substrate (target) is synthesized from clinical and electro-anatomical information. This study...
4.
van der Ree M, Hoeksema W, Luca A, Visser J, Balgobind B, Zumbrink M, et al.
Radiother Oncol
. 2023 Sep;
189:109910.
PMID: 37709052
Background: Stereotactic arrhythmia radioablation (STAR) appears to be beneficial in selected patients with therapy-refractory ventricular tachycardia (VT). However, high-dose radiotherapy used for STAR-treatment may affect functioning of the patients' implantable...
5.
van der Ree M, Herrera Siklody C, Le Bloa M, Pascale P, Porretta A, Teres C, et al.
Front Cardiovasc Med
. 2023 Aug;
10:1213165.
PMID: 37547255
Background: Cardiac sarcoidosis is associated with heart failure, conduction abnormalities, and life-threatening arrhythmias including ventricular tachycardia (VT). Radiotherapy has been suggested as a treatment for extra-cardiac sarcoidosis in patients refractory...
6.
Bergeman A, Hoeksema W, van der Ree M, Boersma L, Yap S, Verheul L, et al.
Neth Heart J
. 2023 Jul;
31(7-8):309-314.
PMID: 37498467
Background: The genetic risk haplotype DPP6 has been linked to familial idiopathic ventricular fibrillation (IVF), but the associated long-term outcomes are unknown. Methods: DPP6 risk haplotype-positive family members (DPP6 cases)...
7.
van der Ree M, Luca A, Herrera Siklody C, Le Bloa M, Pascale P, Porretta A, et al.
Heart Rhythm
. 2023 May;
20(8):1206-1207.
PMID: 37225114
No abstract available.
8.
Groeneveld S, Verheul L, van der Ree M, Mulder B, Scholten M, Alings M, et al.
JACC Clin Electrophysiol
. 2023 Feb;
9(3):345-355.
PMID: 36752476
Background: Idiopathic ventricular fibrillation (iVF) is a diagnosis of exclusion. Systematic diagnostic testing is important to exclude alternative causes for VF. The early use of "high yield" testing, including cardiac...
9.
van der Ree M, Dieleman E, Visser J, Planken R, Boekholdt S, de Bruin-Bon R, et al.
Europace
. 2023 Feb;
25(3):1015-1024.
PMID: 36746553
Aims: Stereotactic arrhythmia radiotherapy (STAR) is suggested as potentially effective and safe treatment for patients with therapy-refractory ventricular tachycardia (VT). However, the current prospective knowledge base and experience with STAR...
10.
van der Ree M, de Bruin-Bon R, Balgobind B, Hoeksema W, Visser J, van Laarhoven H, et al.
Heart Rhythm
. 2022 Sep;
20(1):149-151.
PMID: 36084840
No abstract available.